Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk

C Schilling; J Knight; D Mortimer; D Petrie; P Clarke; J Chalmers; A Kerr; R Jackson

Journal article

Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk

C Schilling, J Knight, D Mortimer, D Petrie, P Clarke, J Chalmers, A Kerr, R Jackson

Health Policy | ELSEVIER IRELAND LTD | Published : 2017

DOI: 10.1016/j.healthpol.2017.09.022

Abstract

Objectives To compare the determinants of initial statin prescribing between New Zealand and Australia. New Zealand has a system-wide absolute risk-based approach to primary care cardiovascular disease (CVD) management, while Australia has multiple guidelines. Method Classification and Regression Tree (CART) analysis of two observational studies of primary care CVD management from New Zealand (PREDICT-CVD) and Australia (AusHeart). Over 80% of eligible New Zealanders have been screened for CVD risk. PREDICT-CVD is used by approximately one-third of New Zealand GPs to perform web-based CVD risk assessment in routine practice, with the sample consisting of 126,519 individuals risk assessed bet..

View full abstract

University of Melbourne Researchers

Chris Schilling Author

Philip Clarke Author

Related Projects (2)

ECONOMIC EVALUATION OF POLICIES TO MANAGE AND PREVENT CARDIOVASCULAR DISEASE &AMP; DIABETES IN AUSTRALIA

This Research Fellowship will use health economics to deliver health system impact. It will focus on: (i) mechanisms for setting prices for ..

DEVELOPMENT AND VALIDATION OF A HEALTH POLICY SIMULATION MODEL FOR CARDIOVASCULAR DISEASE

The research is focused on evaluating policies associated with treating cardiovascular disease in Australia (CVD). It will involve the devel..

Grants

Awarded by National Health and Medical Research Council

Funding Acknowledgements

This work was supported by Monash University, the University of Auckland, the University of Melbourne, and the NHMRC research grant "Development and validation of a health policy simulation model for cardiovascular disease; GNT1084347". Philip Clarke was supported by NHMRC Fellowship GNT1079621. The authors declare that they have no conflicts of interest.